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ABSTRACT Null mutants are essential for analyzing gene function. Here, we describe a simple and efﬁcient
method to generate Caenorhabditis elegans null mutants using CRISPR/Cas9 and short single stranded
DNA oligo repair templates to insert a universal 43-nucleotide-long knock-in cassette (STOP-IN) into the
early exons of target genes. This STOP-IN cassette has stop codons in all three reading frames and leads to
frameshifts, which will generate putative null mutations regardless of the reading frame of the insertion
position in exons. The STOP-IN cassette also contains an exogenous Cas9 target site that allows further
genome editing and provides a unique sequence that simpliﬁes the identiﬁcation of successful insertion
events via PCR. As a proof of concept, we inserted the STOP-IN cassette at a Cas9 target site in aex-2 to
generate new putative null alleles by injecting preassembled Cas9 ribonucleoprotein and a short synthetic
single stranded DNA repair template containing the STOP-IN cassette and two 35-nucleotide-long ho-
mology arms identical to the sequences ﬂanking the Cas9 cut site. We showed that these new aex-2 alleles
phenocopied an existing loss-of-function allele of aex-2. We further showed that the new aex-2 null alleles
could be reverted back to the wild-type sequence by targeting the exogenous Cas9 cut site included in the
STOP-IN cassette and providing a single stranded wild-type DNA repair oligo. We applied our STOP-IN
method to generate new putative null mutants for 20 additional genes, including three pharyngeal muscle-
speciﬁc genes (clik-1, clik-2, and clik-3), and reported a high insertion rate (46%) based on the animals we
screened. We showed that null mutations of clik-2 cause recessive lethality with a severe pumping defect
and clik-3 null mutants have a mild pumping defect, while clik-1 is dispensable for pumping. We expect that
the knock-in method using the STOP-IN cassette will facilitate the generation of new null mutants to un-
derstand gene function in C. elegans and other genetic model organisms.
KEYWORDS
CRISPR/Cas9
C. elegans
null allele
STOP-IN
genome editing
An essential goal of genetics is to understand gene function. Loss-
of-function or null mutants, in which gene activity is reduced or com-
pletely lost, are valuable reagents that enable this goal. Caenorhabditis
elegans has become an important model organism since the ﬁrst de-
scription of its genetics by Brenner (Brenner 1974), allowing study of
conserved mechanisms underlying many important biological processes,
such as programed cell death, neural development, and RNA interfer-
ence (Corsi et al. 2015). Among other useful features, the availability
of a large number of loss-of-function and null C. elegansmutants has
been important for the success of C. elegans research. Many of these
mutants have been isolated by screening worms treated with muta-
gens or transposons (Vallin et al. 2012; C. elegans Deletion Mutant
Consortium 2012; Thompson et al. 2013; Kutscher and Shaham
2014). While these mutants allow us to infer the nature of a gene’s
normal function and to place genes into genetic networks using epis-
tasis analyses, many of them may also contain background mutations
that can confound the interpretation of the functional importance of
the gene of interest. In addition, a signiﬁcant fraction of C. elegans
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genes have only reduction-of-function alleles or simply no mutant
alleles at all. As such, an efﬁcient and convenient way to generate null
mutants in the wild-type background would be of great interest.
Here, we report a simple and robust method using CRISPR/Cas9
and a universal stop knock-in (STOP-IN) cassette to achieve this
purpose.
The CRISPR/Cas9 system was originally identiﬁed in bacterial and
archaeal immune systems as a defense against viruses (Wiedenheft et al.
2012). Cas9 protein from the bacterium Streptococcus pyogenes is an
RNA-guided endonuclease that creates site-speciﬁc cleavage of double
stranded DNA. Cas9 protein complexes with two small RNAs to form
a functional Cas9 ribonucleoprotein: a CRISPR RNA (crRNA) that de-
termines the target speciﬁcity of Cas9 nuclease activity, and a trans-
activating crRNA (tracrRNA) that acts as a scaffold (Gasiunas et al. 2012;
Jinek et al. 2012). The Cas9 ribonucleoprotein recognizes the DNA target
that is homologous to the ﬁrst 20 nucleotides of the crRNA guide
sequence and is followed by a protospacer adjacentmotif (PAM), which
in the case of S. pyogenes is 59-NGG-39, and generates a double-strand
break three base pairs upstream of the PAM site (Figure 1A). After the
break is generated, the DNA strands can be re-joined through error-
prone non-homologous end joining (NHEJ) or precise homology di-
rected repair (HDR). The CRISPR/Cas9 system was engineered for
modiﬁcation of genomes in mammalian cells and has since revolution-
ized the ﬁeld of genome editing (Cong et al. 2013; Mali et al. 2013).
The CRISPR/Cas9 system has also been successfully adopted for
genome editing in C. elegans by injecting plasmids, RNA, and/or pro-
tein of the CRISPR/Cas9 system in the gonads of adult hermaphrodites
(Chen et al. 2013; Cho et al. 2013; Katic and Großhans 2013; Lo et al.
2013; Tzur et al. 2013; Waaijers et al. 2013; Friedland et al. 2013;
Dickinson et al. 2013; Chiu et al. 2013). Different strategies have
been described to facilitate identiﬁcation of desired genome editing
events (reviewed by Dickinson and Goldstein 2016). For example,
co-conversion and co-CRISPR methods effectively enrich for animals
that have the desired genome alterations: animals with successful ge-
nome editing at the co-conversion locus with a dominant visible phe-
notype, such as dpy-10, are likely to have edits at another independent
locus (Ward 2014; Kim et al. 2014; Arribere et al. 2014).
Several CRISPR approaches have been described to generate loss-of-
function alleles or null alleles for C. elegans genes, in which deletions,
insertions, or premature nonsense mutations were introduced at spe-
ciﬁc loci. Without a repair template, error-prone NHEJ generally cre-
ates deletions or insertions with unpredictable ﬂanking sequences in
target genes after Cas9 cutting (Katic and Großhans 2013; Friedland
et al. 2013; Chiu et al. 2013; Chen et al. 2014). In addition, some NHEJ-
mediated insertions or deletions could be in-frame, which may only
marginally reduce gene activity. For mutants that have unknown phe-
notypes, PCR is commonly used to detect the desired genome edit. The
detection of small deletions and/or insertions via PCR is rather labori-
ous, as the PCR products generally need to be denatured, annealed, and
treated with enzymes that recognize mismatches, such as CEL I nucle-
ase and T7 Endonuclease I, to identify candidates with successful edit-
ing. When repair templates with long homology arms are used, HDR
can produce precise insertion of large exogenous sequences, such as gfp
or an antibiotic selection cassette, to disrupt or replace the gene of
interest (Chen et al. 2013; Tzur et al. 2013; Norris et al. 2015). Although
several vectors have been developed to facilitate the preparation of such
repair templates (Dickinson et al. 2015; Schwartz and Jorgensen 2016),
laborious molecular cloning may be required to construct repair tem-
plate plasmids with long homology arms. In addition, large insertions
or deletions may affect the expression of the neighboring genes (Tzur
et al. 2013). Single stranded DNA oligos with short homology arms
(30-60 nucleotides) can efﬁciently serve as repair templates to insert
up to 130 nucleotides into the C. elegans genome with CRISPR/Cas9
(Paix et al. 2017). In previous attempts to make knock-outs by in-
troducing a single stop codon, the reading frame of the target gene
would need to be considered and additional mutations were also
needed to prevent re-cutting by Cas9 and/or to introduce a restric-
tion enzyme site for detection of successful genome modiﬁcation
(Paix et al. 2017).
We sought to develop an easy and efﬁcient CRISPR/Cas9method to
generate putative nullmutants with pre-deﬁnedmutations inC. elegans.
To this end, we designed a 43-nucleotide-long universal stop knock-in
(STOP-IN) cassette that will create stop codons and frameshifts in all
three reading frames. We describe an efﬁcient co-conversion CRISPR
method in which preassembled Cas9 ribonucleoprotein and short sin-
gle stranded DNA oligo repair templates are used to generate putative
null alleles by inserting the STOP-IN cassette into the coding regions of
target genes. The universal STOP-IN cassette allows the usage of a
common internal primer for easy detection of putative null alleles with
successful insertion via PCR. The resultant null alleles can be reverted
to the original wild-type sequence via a second oligo-directed CRISPR/
Cas9 editing targeting the exogenous Cas9 target site included in the
STOP-IN cassette.
MATERIALS AND METHODS
Maintenance of strains
All C. elegans strains were maintained on NGM plates seeded with the
E. coli strain OP50 as food, at room temperature, as described (Brenner
1974). The following strains were used: wild type (theN2Bristol strain),
JT3 aex-2(sa3) X, and a balancer strain FX30236 tmC30[ubc-17
(tmIs1243)] X (Dejima et al. 2018). Strains generated in this study are
listed in Supplemental Table S1.
Design of guide RNA sequences
All crRNAs and the universal tracrRNA were chemically synthesized
(the Alt-R system from IDT, Coralville, IA). Synthetic crRNAs and
tracrRNAwere dissolved in nuclease-free water (IDT) tomake 100mM
working stocks. The guide sequences of all crRNAs used in this
study are provided in Supplemental Table S2. We used a CRISPR
guide sequence selection tool (http://genome.sfu.ca/crispr/search.
html) designed for the C. elegans genome (Au et al. 2018) to identify
guide sequences within the coding sequences of target genes; one
guide sequence was selected for each gene of interest. We only
selected guide sequences followed by the PAM site (59-NGG-39) for
Streptococcus pyogenes Cas9. The guide sequences in early exons
shared by all known isoforms of the gene of interest were preferred,
as we suspected early stop codons and frameshifts introduced by our
STOP-IN method in these regions would be more likely to produce
putative null mutants.
Design of repair DNA oligos
All single stranded DNA repair oligos (113 nucleotides) were syn-
thesized (4nmol, Ultramer DNA oligos from IDT, Coralville, IA) and
diluted in nuclease-free water (IDT). The sequences of DNA repair
oligos used in this study are described in Supplementary Table S2.
Our universal stop knock-in (STOP-IN) cassette (43 nucleotides, 59-
GGGAAGTTTGTCCAGAGCAGAGGTGACTAAGTGATAAGCT-
AGC-39) is composed of an exogenous Cas9 target site with a PAM
site (underlined) that has been shown to work in C. elegans (Paix et al.
2017), multiple stop codons in all three reading frames, and the
recognition site of the restriction enzyme NheI (Figure 1B).
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To achieve high knock-in efﬁciency, we implemented two rules for
the design of single-stranded DNA repair oligos. First, the efﬁciency of
homology directed repair (HDR) correlates inversely with the distance
between homology arms and theCas9 cut site (Paquet et al. 2016). Thus,
in addition to the STOP-IN cassette, each single stranded DNA repair
oligo also contains two unique homology arms (35 nucleotides for
each) that are identical to sequences immediately ﬂanking the Cas9 cut
site, such that the universal STOP-IN cassette will be directly inserted
Figure 1 The CRISPR/Cas9 pipeline to generate null mutants by inserting a universal stop knock-in (STOP-IN) cassette. (A) Diagram showing the
recognition of the target DNA by Cas9 ribonucleoprotein from Streptococcus pyogenes. The ribonucleoprotein complex of Cas9 with crRNA and
tracrRNA recognizes the target DNA with the ﬁrst 20 nucleotides (nt) of crRNA homology (the guide sequence) preceding a PAM site (‘5-NGG-39)
and generates a double-strand break three nucleotides 59 of the PAM site. (B) Design of the 43-nucleotide-long universal stop knock-in (STOP-IN)
cassette (represented by the red rectangle) used in this study, which includes an exogenous Cas9 target site (the PAM site is underlined), stop
codons and frameshifts in all three reading frames, and the recognition site for the restriction enzyme NheI. RF, reading frame, as indicated by
gray boxes. Cyan and purple boxes represent the stop codons TAA and TGA, respectively. Reading frames 1 and 2 have two stop codons;
reading frame 3 has one stop codon. (C) The recipe of the ribonucleoprotein injection mixture and the workﬂow of the CRISPR/Cas9 protocol to
generate null mutants. With the co-conversion method, two crRNAs and two DNA repair oligos (one pair for the co-conversion marker, dpy-10 or
unc-58, and the other pair for the target gene) are included in the same injection mixture; the mixture is directly injected into the gonads of adult
hermaphrodites. Animals with genomes affected by CRISPR/Cas9 and template-directed repair are identiﬁed by the co-conversion marker
phenotype; in the ﬁgure, these are roller animals with dpy-10 conversion. (D and E) Design of the DNA repair oligo for the target gene. The
oligo contains two 35-nucleotide-long homology arms identical to the sequences ﬂanking the Cas9 cut site and on the same strand as the PAM
site (59-NGG-39). If the PAM site is on the coding strand (1D), the STOP-IN cassette sequence as shown in (1B) is included in between the two
homology arms to comprise the DNA repair oligo. If the PAM site is on the non-coding strand (1E), the reverse complement of the STOP-IN
cassette sequence as shown in (1B) is added between the two homology arms to make the DNA repair oligo. (F) Diagram showing the placement
of primers for PCR reactions to detect successful knock-in events. P1 and P3 are outer primers that are speciﬁc to the target gene, while P2 is a
common internal primer within the universal STOP-IN cassette. These primers can be used to detect the successful insertion of the STOP-IN
cassette via PCR, as shown in the cartoon agarose gels below.
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at the cut site. In addition, successful insertion will disrupt the original
Cas9 target site preventing the knock-in locus from being re-cut by
Cas9, removing the need to introduce additional mutations in the re-
pair template. Second, it has also been demonstrated that the sense of
the single strandedDNA repair oligo relative to the PAM site affects the
genome editing efﬁciency: if the modiﬁcation occurs 59 to the PAM site
(59-NGG-39), the DNA repair oligo containing sequence from the same
strand as the PAM site has higher knock-in efﬁciency; if the modiﬁca-
tion occurs 39 to the PAM site, the DNA repair oligo containing the
reverse complement sequence of the strand with the PAM site has
higher knock-in efﬁciency (Behnom Farboud and Barbara J. Meyer,
personal communication). As the universal STOP-IN cassette needs to
be inserted at the Cas9 cut site on the coding strand (three nucleotides
upstream of the PAM site) to generate putative null mutants, the single
strandedDNA oligo should be on the same strand that carries the PAM
site (59- NGG-39) for high knock-in efﬁciency. Thus, the direction of
the single stranded DNA repair oligo (sense or anti-sense) is dependent
on whether the PAM site is on the coding strand or the non-coding
strand (Figure 1E). A detailed step-by-step protocol to design DNA
repair oligos is included in Supplemental File S1.
Microinjection of Cas9 ribonucleoprotein
We used a co-conversion method (Arribere et al. 2014) for all CRISPR/
Cas9 genome editing experiments in this study. We injected preassem-
bled Cas9 ribonucleoprotein and synthetic single stranded DNA oligos
as repair templates (Paix et al. 2015; Figure 1C). Using the plasmid
pHO4d-Cas9 (Addgene plasmid # 67881), which was a gift from Mi-
chael Nonet (Fu et al. 2014), the Cas9 protein (eluted in the buffer with
20 mM HEPES pH 7.5, 150 mM KCl, 10% Glycerol, 1 mM DTT) was
made as previously described (Paix et al. 2015). To anneal tracrRNA
and crRNAs at a 1:1 ratio, 2.5 ml of 100 mM tracrRNA, 0.5 ml of
100 mM dpy-10 crRNA (for co-conversion), and 2.0 ml of 100 mM
crRNA targeting the gene of interest were mixed in a PCR tube, in-
cubated at 94 for 2 min in a PCR machine, and cooled to room
temperature at the bench. The injection solution was prepared as fol-
lows: 3.4 mg/mL Cas9 protein, 45.9 mM annealed guide RNA mixture,
0.51 mMDNA repair oligo for the gene of interest, and 0.25 mMDNA
repair oligo for the co-conversion marker dpy-10. The solution was
spun at 14549 rcf for 1 min, put on ice and was used right away.
The mixture was injected into the germline syncytium of wild-type
C. elegans according to a standard microinjection procedure (Mello
and Fire 1995). We injected 15-20 young adults (P0), cultured each
injected P0 on its own NGM Petri plate at room temperature, and
picked F1 progeny with the co-conversion phenotype after 3-4 days.
For the experiment to obtain aex-2 revertants, the aex-2(sy1078) ani-
mals were used for injection. When using unc-58 as the co-conversion
marker, we slightly modiﬁed the protocol by changing the ratio of
crRNAs in the annealed guide RNA mixture (1.0 ml of 100 mM
unc-58 crRNA, and 1.5 ml of 100 mM crRNA for the target gene)
and the ﬁnal concentration of the repair template for unc-58 (0.51 mM)
in the injection solution. A step-by-step protocol is provided in
Supplemental File S1.
Screen for successful knock-in events by PCR
3-4 days aftermicroinjection, we selected F1 animals with the dominant
co-conversion phenotype (Roller phenotype for dpy-10), placed them
singly onto individual NGMPetri plates, and conﬁrmed the presence of
the co-conversion phenotype in F2 progeny (Figure 1C). As CRISPR/
Cas9 via injecting preassembled ribonucleoproteinmay induce targeted
somatic mutations in the F1 progeny (Cho et al. 2013), we only geno-
typed F2 progeny to identify F1 animals with heritable genome editing.
For each of those F1 animals that produced F2 progeny with the
co-conversion phenotype, about 10 young F2 animals were lysed and
genotyped (See Supplemental File S1 for a detailed protocol). Two PCR
reactions were used: one using the common reverse inner primer
(oHP013r: 59-GCTTATCACTTAGTCACCTCTGCTC-39) within the
repair template and a forward primer speciﬁc to the target gene to
identify F1 animals with successful insertion of the STOP-IN cas-
sette; the other one using two outer primers speciﬁc to the target
gene to determine if the F1 animals were heterozygotes for the
knock-in allele (Figure 1F). The two outer primers speciﬁc to the
target gene were chosen to get a relative small PCR amplicon (,
500 bp) such that a small size difference (43-bp insertion of the
STOP-IN cassette) could easily be detected on a 2.5% agarose gel.
The original F1 animals giving F2 progeny with the predicted
knock-in bands from both PCR reactions were considered positive
F1 clones with the desired knock-in alleles. The knock-in efﬁciency
(“% of KI” in Table 1) for each genome editing experiment was
calculated as the number of positive F1 clones divided by the total
number of F1 plates genotyped. For positive F1 animals that were
heterozygotes, several F2 progeny from each plate were singled out
to identify homozygote F2 animals by genotyping F3 progeny using
the same outer primer set. The successful insertion of the STOP-IN
cassette in homozygous animals was conﬁrmed by Sanger sequenc-
ing (Laragen, Culver City, CA) of PCR products with the two outer
primers. Primer sequences used for genotyping are provided in
Supplemental Table S2.
For reversion of the aex-2(sy1078) null mutants, we injected young
adults of aex-2(sy1078)mutants (P0) using the same protocol described
above. We screened the F1 generation for non-constipated F1 animals
using a dissecting microscope and transferred each candidate onto an
individual plate. Several wild-type F2 progeny from each plate were
singled out to identify homozygotes for revertant aex-2 alleles by
the absence of constipated worms in the next generation. Likely
homozygous aex-2 revertants were genotyped with the same set of
outer primers used to detect aex-2(sy1078) and the revertant wild-
type alleles were conﬁrmed by Sanger sequencing.
Behavioral assays
The defecation motor program was assayed as previously described
(Wang et al. 2013) with modiﬁcations. Brieﬂy, L4 animals were col-
lected, and then 24 hr later transferred to newNGMPetri plates seeded
with E. coli OP50, and observed under a dissecting stereomicroscope.
Each worm was scored for six consecutive defecation cycles. The pos-
terior body wall muscle contraction (pBoc) and enteric muscle contrac-
tion (EMC) during each defecation cycle were recorded using Etho, an
event logging Java program (http://depts.washington.edu/jtlab/software/
otherSoftware.html) (Thomas 1990). “EMC per cycle” for each animal
was calculated as the ratio of EMC to pBoc. Ten individual animals were
assayed for each genotype.
Pumping assays were performed as follows: 24 hr prior to the assay,
L4 animals of each genotype were moved onto fresh NGM Petri plates
with E. coliOP50. The next day, adult animals were picked in pairs onto
new NGM plates seeded with OP50 and allowed to acclimate for
10 min. Animals were then recorded on a Wild Makroskop M420
dissecting microscope at 80x magniﬁcation for 30 sec. The number
of pumping events observed in 30 sec was doubled to obtain the pump-
ing rate (pumps/min).
Microscopy
DIC images of the constipated worms in Figure 2D were taken using a
Plan Apochromat 40x/1.4 Oil DIC objective in a Zeiss Imager Z2
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microscope equipped with an Axiocam 506 Mono camera using ZEN
Blue 2.3 software.
Statistics
Where appropriate, Chi-square test or One-way ANOVAwith Tukey’s
post-test or with Dunn’s multiple comparisons test were applied
(GraphPad Prism) to determine if there were signiﬁcant differences
between genotypes, as indicated in results or ﬁgure legends.
Data availability
Strains and plasmids are available upon request. The authors afﬁrm
that all data necessary for conﬁrming the conclusions of the article are
present within the article,ﬁgures, tables, and supplemental information.
Supplemental material available at Figshare: https://doi.org/10.25387/
g3.7086647.
RESULTS
Design of our universal STOP-IN cassette
We aimed to develop a cloning-free and streamlined protocol for the
design of single stranded DNA repair templates to generate putative
mutantswithwell-deﬁnedmutationswithCRISPR/Cas9and to simplify
the detection of knock-in alleles with PCR. To this end, we designed a
43-nucleotide-long universal stop knock-in (STOP-IN) cassette that
would create putative null mutants when inserted within the exons,
regardlessof the reading frame.The cassette containsanexogenousCas9
target sitewithaPAMsite thathasbeenshownto functionwhen inserted
into the C. elegans genome (Paix et al. 2017), followed by ﬁve stop
codons, as well as a NheI restriction enzyme site (Figure 1B). Once
inserted into the coding stand, this STOP-IN cassette will generate stop
codons in three reading frames (a tandem pair of stop codons for two of
the three frames and one stop codon for the third frame; Figure 1B). The
universal STOP-IN cassette is 43 nucleotides and thus will also create a
frameshift in the target gene even if stop codon readthrough occurs.
Insertion of similar cassettes with stop codons in three reading
frames has been used to knockout gene activity in zebraﬁsh, C. elegans
and mammalian cell lines (Gagnon et al. 2014; Farboud and Meyer
2015;Maruyama et al. 2015). The design of our STOP-IN cassette offers
some unique features. The included exogenous Cas9 target site allows
future re-editing of the genomic locus, and the NheI site can be used
for PCR/RFLP detection. Our cassette also allows the use of a single
universal inner primer (e.g., we used the universal reverse primer P2:
59-GCTTATCACTTAGTCACCTCTGCTC-39) for detection of suc-
cessful knock-in events, when combined with a gene-speciﬁc forward
outer primer (P1 in Figure 1F). In addition, the insertion of the uni-
versal STOP-IN cassette (43 bp) is easy to identify by size shift on
agarose gel electrophoresis of a PCR product ampliﬁed using an outer
primer pair ﬂanking the target cut site(P1 and P3 in Figure 1F), when
the PCR product is less than 500 bp.
Generation of putative aex-2 null mutants
To test if insertion of our universal STOP-IN cassette into the coding
sequence could generate null mutants, we chose the gene aex-2, which
has distinctive and easily observable loss-of-function phenotypes. aex-2
encodes a G protein-coupled receptor essential for rhythmic enteric
muscle contraction (EMC) during the C. elegans defecation motor pro-
gram. Strong loss-of-function aex-2(sa3) mutants almost completely
lack EMCs, leading to a constipated phenotype with a distended in-
testinal lumen (Mahoney et al. 2008; Figures 2D-2E). We tested
whether new aex-2 alleles generated using our universal STOP-IN
cassette had the same phenotype as aex-2(sa3) animals.
We ﬁrst selected a guide sequence in the third exon of the aex-2 gene
to insert the STOP-IN cassette with CRISPR/Cas9 (Figures 2A-2B; see
Supplemental File S1 for a detailed protocol). Following microinjection
and identiﬁcation of F1 animals showing the co-conversion marker
(Figure 1C), 7 of the 16 F1 lines genotyped (44%) had successful in-
sertion of the STOP-IN cassette (Figure S1; Table 1). Two different
STOP-IN alleles of aex-2were retained (sy1078 and sy1079), originating
n Table 1 Summary of our CRISPR/Cas9 knock-in results
Target gene Allele Guide sequence
# of F1 plates
genotyped # of KI % of KI Lethal
Co-conversion
marker
clik-1 sy1084 and sy1085 CTCTGGCTCTTGGTTCTCGT 46 24 52% dpy-10
clik-2 sy1122 and sy1123 GTATCCTTGCTTCTTGTCCT 105 28 27% Yes dpy-10
clik-3 sy1082 and sy1083 GTCACGTGGTGTTCCGAAAC 46 6 13% dpy-10
clik-3 sy1086 and sy1087 ATTGCTTGGCACCTCGACGG 38 13 34% dpy-10
T05C3.2 sy1080 and sy1081 AGAACGAAACGCGCTAATGG 45 16 36% dpy-10
cul-3 sy1153 and s1154 ACTTTTGAAGCGTGCCATAC 40 12 30% Yes dpy-10
dlg-1 sy1155 and sy1156 ACACTCCTACAACAGTCGTC 46 17 37% Yes dpy-10
ubq-1 sy1157 and sy1158 AAAAACTATCACCCTGGAGG 19 2 11% Yes dpy-10
hpo-29 sy1159 and sy1160 ATCTCCGTTCATATGTCTGC 12 2 17% Yes dpy-10
Y106G6H.8 sy1076 and sy1077 AGGCCAGCCAGACGAATAAT 24 21 88% dpy-10
aex-2 sy1078 and sy1079 ATTACTGCAGCGACATGGGG 16 7 44% dpy-10
Y71H2AM.20 sy1176 and sy1177 TCTCCTAGCCAGCGTTCTTC 22 4 18% Yes dpy-10
set-16 sy1178 and sy1179 CTGACGTTGTTGCTGCATGG 23 7 30% Yes dpy-10
C01B10.10 sy1114 and sy1115 GCTCTGGGTCCATGTTGAAT 24 20 83% dpy-10
C56G2.15 sy1120 and sy1121 ACGACATTGGAGGGGACTGA 23 21 91% dpy-10
C01B10.4 sy1131 and sy1132 CATTTGGAAGGTGCAGAGAT 23 23 100% dpy-10
C23H4.2 sy1163 and sy1164 GCTTTGCAAACGGAACACTC 23 18 78% dpy-10
C04G6.4 sy1165 and sy1166 ATATTTGGCTGGAGAACTGG 24 15 63% unc-58
ttc-36 sy1167 and sy1168 CGAGAGAGAAGGTGTCGCGT 24 14 58% unc-58
ZC376.2 sy1170 and sy1171 GGAGGCGAAGGAGTATAAAG 24 19 79% dpy-10
cpn-4 sy1172 and sy1173 TGTTGAAGCTGGATACTTGT 24 13 54% dpy-10
Y55F3BL.4 sy1174 and sy1175 CTGGTCACTGGTAGAAAAGC 23 20 87% unc-58
Footnote: KI, knock-in events. % of KI = # of KI / # of independent plates genotyped.
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from different F1 animals, and conﬁrmed by Sanger sequencing
(data not shown). Both sy1078 and sy1079 animals, behaved similarly
to aex-2(sa3) mutants and were completely defective in EMC during
the defecation cycle and had distended intestinal lumens (Figure 2D
and 2E), consistent with the idea that both sy1078 and sy1079 were
null alleles. Thus, our STOP-IN method can generate putative null
alleles of target genes.
Reversion of aex-2 mutants to wild type with a second
CRISPR/Cas9 editing
Next, we tested if we could revert the STOP-IN alleles of aex-2 back to
wild type using the exogenous Cas9 target site that was included the
STOP-IN cassette. We targeted the aex-2(sy1078) mutants using a
crRNA for the exogenous Cas9 target site, and a 71-nuceotide-long
single stranded DNA repair oligo with wild-type aex-2 sequence
(Figure 2C). We obtained F1 animals that, unlike the parental aex-2
(sy1078), were not constipated, indicating that they contained rever-
tant alleles and possessed a normal defecation cycle. We retained two
revertant aex-2 alleles (sy1078sy1090 and sy1078sy1091) and con-
ﬁrmed the wild-type sequence of the aex-2 locus around the Cas9
target site with Sanger sequencing. Both aex-2 revertants showed
wild-type levels of EMC and had normal intestinal lumens (Figures
2E-2F). Thus, the null alleles with the STOP-IN cassette can be
reverted back to wild type. Reversion of a null mutant to wild type
offers a convenient and convincing way to prove that the phenotype
associated with a null mutation is caused by loss of the gene’s
function.
Calponin-Like protein knockouts have pharyngeal
pumping defects
We used our STOP-IN method to generate null alleles for the poorly
understood and characterized clik genes. These genes have been shown
Figure 2 Genome engineering of the aex-2 gene. (A) The gene structure of aex-2. The black arrowhead indicates the position of the Cas9 target
site in the third exon of aex-2, which we used to insert the universal STOP-IN cassette to generate the two new aex-2 null alleles, sy1078 and
sy1079. The asterisk denotes the mutation sa3, a strong loss-of-function allele of aex-2. Black boxes are exons and the white box is the 39 UTR.
The lines connecting the black boxes are introns. Scale bar, 500 bp. (B) Scheme showing the generation of putative aex-2 null alleles, sy1078 and
sy1079, using CRISPR/Cas9 and a DNA repair oligo with the universal STOP-IN cassette. (C) Diagram showing the reversion of aex-2(sy1078) to
wild-type sequence, using the exogenous Cas9 target site included in the STOP-IN cassette and a wild-type DNA oligo with two 35-nucleotide-
long homology arms. (D) Differential interference contrast (DIC) images showing the constipation phenotypes of young adults with indicated
genotypes. Yellow lines outline the posterior intestinal lumens. Compared to wild-type and aex-2(sy1078sy1091) animals, aex-2(sa3) and aex-
2(sy1078) mutants both have distended intestinal lumens. Scale bar, 50 mm. (E) Quantiﬁcation of enteric muscle contraction (EMC) during the
defecation motor program in adult animals with indicated genotypes. Each dot represents the percentage of EMC observed per defecation cycle
from an individual animal. n = 10 animals for all genotypes. Horizontal bars indicate the mean; vertical bars are SEM. , P , 0.001 and , P , 0.01,
compared to wild type; ###, P , 0.001 and ##, P , 0.01, compared to aex-2(sy1078); One-way ANOVA with Dunn’s multiple comparisons test.
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to be highly expressed and almost completely speciﬁc for pharyn-
geal muscle: clik-1, clik-2, and clik-3 (Yuet et al. 2015). These genes
encode proteins that share some homology with human Calponin-1,
a protein found in smooth muscle cells. Two unique types of pro-
tein domains are found in human Calponin-1: a single calponin
homology (CH) domain, and multiple calponin family repeats
(CFRs). CLIK-1, CLIK-2, and CLIK-3 in C. elegans all contain
varying numbers of CFRs but no CH domains (Figure 3A). CFRs
are thought to be actin-interacting domains, negatively affecting
actin-coﬁlin interactions (Yamashiro et al. 2007). Given the highly
speciﬁc expression of the clik genes in the pharynx, we generated
putative null mutants of these genes and assayed for pumping
defects.
We inserted the STOP-INcassette in early exons for clik-1 and clik-2,
both of which have single isoforms (Figure 3A). clik-3 has four iso-
forms, of which the c isoform is the shortest and consists of the last
exon. Thus, we created alleles of clik-3 in which the STOP-IN cassette
was inserted at two different locations: one in the second exon (sy1086
and sy1087, affecting isoforms a, b, and d) and the other in the last exon
(sy1082 and sy1083, affecting all isoforms, Figure 3A).
We used these alleles to determine if any of these three genes are
involved in the regulation of pharyngeal pumping. clik-1 null mutants
(sy1084 and sy1085)were similar to the wild type, suggesting that clik-1
is not essential for pharyngeal pumping (Figure 3B). For clik-3, we
found that only the sy1082 and sy1083 alleles affecting all isoforms
displayed a mild (14% decrease) pumping defect. The sy1086 and
sy1087 alleles affecting isoforms a, b, and d, did not exhibit pumping
defects (Figure 3B).
We were unable to homozygose the clik-2 null alleles with the
STOP-IN cassette, sy1122 and sy1123, leading us to believe clik-2 null
mutants were lethal. We thus created balanced sy1122/tmC30[tmIs1243]
and sy1123/tmC30[tmIs1243] strains using a multiple-inversion balancer
(Dejima et al. 2018). These animals appeared wild-type for growth and
pumping. However, their progeny included tiny, starved L1-arrested
animals which did not appear to pump, in roughly Mendelian ratios
(Figures 3C-3D). Close observation of these arrested animals showed
barely perceptible fasciculation of pharyngeal muscles and the grinder,
but no full contractions. When constructing our clik-2 null mutants, we
also obtained two in-frame insertion alleles for clik-2, sy1116 (57-bp
insertion) and sy1117 (6-bp insertion), which were likely the result of
Figure 3 Mutants of clik genes and pharyngeal pumping. (A) Gene structures of three C. elegans genes encoding Calponin-like proteins: clik-1,
clik-2, and clik-3. Green blocks represent the calponin family repeats (CFRs). Magenta arrowheads indicate Cas9 cut sites where the STOP-IN
cassette was inserted in indicated alleles, except for sy1116 and sy1117, which are small insertions likely resulting from NHEJ during repair. nt,
nucleotide. Scale bars, 500 bp. (B) Quantiﬁcation of pumping rate of clik-1, clik-2, and clik-3 mutants. Each green dot represents the mean
pumping rate of one adult animal over 30 sec on food. The clik-2(sy1116) partial loss-of-function mutants, clik-3(sy1082), and clik-3(sy1083) null
mutants have reduced pumping rates, compare to the wild type. Horizontal bars are the mean, vertical bars are SEM. n = 10 for all genotypes.
 P , 0.05, One-way ANOVA with Tukey’s post-test. (C) Table showing that clik-2(sy1122) and clik-2(sy1123) null mutants are recessive lethal. L1,
the ﬁrst larval stage of C. elegans. The balancer allele used in (C and D) is tmC30[tmIs1243], an aneuploidy-free and structurally deﬁned balancer
for the part of chromosome X where clik-2 is located. (D) Bright-ﬁeld images showing a clik-2(sy1122)/balancer heterozygote (left) and a clik-
2(sy1122) homozygote (right), roughly 16-19 hr after hatching. Scale bars are 20 mm.
Volume 8 November 2018 | CRISPR Knockouts with Stop-In Cassette | 3613
error-prone NHEJ. Pharyngeal pumping rate was decreased by about
15% in sy1116 animals; sy1117 animals appeared normal (Figure 3B).
Robustness of the knock-in method
To test the robustness of our STOP-INmethod to generate putative null
mutants, we used it to generate putative null mutants for 17 additional
genes, most of which did not have null mutants available. We found
that, on average, 46% of F1 animals with a co-conversion phenotype
(Rol for dpy-10 or Unc for unc-58, n = 694) had successful insertion of
the STOP-IN cassette (ranging from 11 to 100%; Table 1). We noticed
that we could not homozygose some of the alleles obtained, and we
speculated that these mutants were likely to be lethal (Table 1). The
knock-in efﬁciency was markedly lower for those putative lethal genes
than for non-lethal genes (27% vs. 59%; n = 267 and 427, respectively;
P , 0.0001, Chi-square test). However, the knock-in efﬁciency for the
lethal genes may be underestimated, as we could not recover the F1
animals for these genes that contained two loss-of-function alleles in-
duced by CRISPR/Cas9.
Whilemost of the candidate F1 animalswithdesired knock-in events
were heterozygotes, we noticed that, for some genes, a small fraction of
F1 animals appeared to be homozygous for the knock-in null alleles,
as they had a correct PCR product with the outer and the internal
primer pair, but only had the bigger PCR band for the knock-in allele
with the outer primer pair (Examples shown in Figures S1 and S2).
However, it was also possible that these putative F1 homozygotes could
be heterozygotes (e.g., one successful knock-in allele and the other allele
with a deletion that removed a region where one or both external
primers bind). Indeed, CRISPR/Cas9 has been shown to create two
independent heritable alleles in a single F1 animal (Cho et al. 2013).
As we generally had more than two F1 animals that are heterozygotes
and to make sure the homozygotes were from single alleles, we always
singled out several F2 progeny from each of independent heterozygous
F1 animals and identiﬁed the homozygotes for null knock-in alleles by
genotyping the F3 progeny.
We also found that partial repair occurred in a small fraction of
animals that we screened, in which the knock-in PCR band with the
outer primer pair appeared to be slightly smaller than the predicted size
(Figures S1 and S2). Such partial repair has been reported before
(Arribere et al. 2014). Thus, we recommended validating homozygous
knock-ins by sequencing the PCR products with the outer primer pair
in F3 homozygotes.
DISCUSSION
We report a simple and robust CRISPR/Cas9 method to generate
putative C. elegans null mutants by inserting a 43-neucleotide-long
knock-in cassette (STOP-IN) in the exons of target genes. We report
high knock-in efﬁciency (46%, n = 694) in F1 co-converted animals that
we screened. We applied our STOP-IN method to generate null
mutants for 21 genes, including three clik genes which are speciﬁcally
expressed in the pharyngeal muscles (Yuet et al. 2015).We showed that
clik-2was essential for pumping inC. elegans. As a proof of concept, we
also showed that null alleles generated by our STOP-INmethod can be
reverted to wild type by a second genome editing event at the exoge-
nous Cas9 target site included in the STOP-IN cassette.
Useful features of our STOP-IN method to generate
null mutants
The main features of our STOP-IN method are as follows. First, it is
straightforward to design the guide sequence and the repair template,
without the need to consider the reading frame of the target gene at the
engineered locus or to introduce other mutations to create a restriction
enzyme or primer binding site for detection of successful insertion.
Second, similar to previously described CRISPR/Cas9 protocols that
used preassembled Cas9 ribonucleoprotein (Cho et al. 2013; Paix et al.
2015), our method is cloning-free, as all the reagents for the genome
editing, including Cas9 protein, tracrRNA, crRNAs, and single
stranded DNA repair oligos, are commercially available. Third, our
method is highly efﬁcient. Speciﬁcally, 46% of F1 animals with a
co-conversion phenotype that we genotyped had the desired knock-in
events. Fourth, combined with an outer primer speciﬁc to the gene
of interest, the common inner primer designed in the universal
STOP-IN cassette makes it easy to detect successful knock-in events
by PCR. Fifth, the null alleles generated with our method can be
reverted to the wild type allele with a second genome editing at the
exogenous Cas9 target sequence included in the STOP-IN cassette.
This can be used to prove that the null mutation in the gene of interest
is causative for the phenotype observed. In principle, the exogenous
Cas9 target site can be also used for other types of genome editing; for
example, inserting an in-frame gfp reporter fused to the gene of
interest.
Potential modiﬁcations of our STOP-IN method
The modular design of the STOP-IN cassette offers opportunities for
future modiﬁcation. While we selected the exogenous Cas9 target site
with a PAM site (59-GGGAAGTTTGTCCAGAGCAGAGG-39) and
the restriction enzyme NheI (59-GCTAGC-39) in our current design,
it can be modiﬁed to generate null alleles, as long as the core sequence
with stop codons in all three reading frames and frameshifts is pre-
served. For example, the exogenous Cas9 target site can be replaced if
an improved sequence is reported for C. elegans. Similarly, the restric-
tion enzyme site can be changed to others, as desired.
In this study, we successfully useddpy-10 or unc-58 as co-conversion
markers to enhance detection of successful knock-in events in target
genes with our STOP-IN method. Other reported co-conversion
markers, such as pha-1, unc-22, sqt-1, and rol-6 (Ward 2014; Kim
et al. 2014; Arribere et al. 2014), should work as well. In principle,
our STOP-IN method should also work with other CRISPR/Cas9
delivery strategies, including injecting mRNA or plasmids that ex-
press Cas9 and guide RNAs (reviewed by Dickinson and Goldstein
2016), instead of preassembled Cas9 ribonucleoprotein used in this
study. While these alternative strategies may make our STOP-IN
method more useful in other experimental systems, we expect that
the knock-in efﬁciency with injection of mRNA or plasmids may be
lower than delivery of preassembled Cas9 ribonucleoprotein (Farboud
et al. 2018).
Unlike deletions obtained from CRISPR/Cas9 protocols not in-
volving HDR, which generally have unpredictable endpoints and
may affect gene activity in unknown ways, null alleles generated using
our STOP-IN method are well deﬁned and reproducible; the alleles of
the target gene generated using the same guide RNA and the same
repair template will have exactly the same genetic mutation. This
consistency will increase robustness in comparing interactions be-
tween genes. With its high efﬁciency, our STOP-IN method can be
used to generate molecularly indistinguishable null alleles of the target
gene in multiple genetic backgrounds: wild-type background, existing
mutants, or in other isolates of the same species. In this way, one can
compare single, double, and even multiple mutants to infer genetic
interactions and examine complex effects of the target gene in different
genetic backgrounds. Our method is particularly useful when close
linkage impedes creation of double-mutant animals by traditional
recombination. In addition, as the relatively small universal STOP-IN
cassette is likely to have minimal effects on gene structure, guide
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sequences in isoform-speciﬁc exons may be used to generate isoform-
speciﬁc null mutations, as we did for clik-3 (Figure 3A). With its easy
design and high knock-in efﬁciency, we envision that our universal
STOP-IN cassette will facilitate the generation of new null mutants in
C. elegans and potentially other genetic model organisms, which can
be used to understand gene function.
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